Marketing and Sales Distribution Alliance AgreementMarketing and Sales Distribution Alliance Agreement • February 29th, 2012 • Novadaq Technologies Inc • Delaware
This Marketing and Sales Distribution Alliance Agreement (the “Agreement”) is made and entered into as of November 29, 2011 (the “Effective Date”) by and between LifeCell Corporation, a Delaware corporation, having its principal place of business at One Millennium Way, Branchburg, NJ 08876 (“LifeCell”) and Novadaq Technologies Inc., a corporation, having its headquarters at 2585 Skymark Avenue, Suite 306, Mississauga, Ontario, Canada L4W 4L5, together with its United States subsidiary Novadaq Corp. (“Novadaq”); LifeCell and Novadaq both together are referred to as the “Parties” and individually as a “Party.”
Marketing and Sales Distribution Alliance AgreementMarketing and Sales Distribution Alliance Agreement • February 29th, 2012 • Novadaq Technologies Inc • Delaware
This Marketing and Sales Distribution Alliance Agreement (the “Agreement”) is made and entered into as of November 29, 2011 (the “Effective Date”) by and between LifeCell Medical Resources Limited, a limited company organized and existing under the laws of the Republic of Ireland but resident in the Cayman Islands, with its principal place of business at Zephyr House, 122 Mary Street, P.O. Box 709, Grand Cayman, Cayman Islands (“LifeCell MR”) and Novadaq Technologies Inc., a corporation, having its headquarters at 2585 Skymark Avenue, Suite 306, Mississauga, Ontario, Canada L4W 4L5, together with its United States subsidiary Novadaq Corp. (“Novadaq”); LifeCell MR and Novadaq both together are referred to as the “Parties” and individually as a “Party.”
Marketing and Sales Distribution Alliance AgreementMarketing and Sales Distribution Alliance Agreement • February 29th, 2012 • Novadaq Technologies Inc • Delaware
This Marketing and Sales Distribution Alliance Agreement (the “Agreement”) is made and entered into as of November 29, 2011 (the “Effective Date”) by and between KCI USA, Inc., a Delaware corporation, with offices at 8023 Vantage Drive, San Antonio, TX 78230 (“KCI US”) and Novadaq Technologies Inc., a corporation, having its headquarters at 2585 Skymark Avenue, Suite 306, Mississauga, Ontario, Canada L4W 4L5, together with its United States subsidiary Novadaq Corp. (“Novadaq”); KCI US and Novadaq both together are referred to as the “Parties” and individually as a “Party.”
DISTRIBUTION AGREEMENTDistribution Agreement • February 29th, 2012 • Novadaq Technologies Inc • New Jersey
This Distribution Agreement (this “Agreement”) is made on November 10, 2011 (the “Agreement Date”) to take effect on January 1, 2012 (the “Effective Date”), by and between Novadaq Technologies, Inc., together with its US subsidiary, Novadaq Corp., having a place of business at 2585 Skymark Avenue, Suite 306, Mississauga, ON L4W 4L5, CANADA (“Novadaq”), and Maquet Cardiovascular LLC, having a place of business at 45 Barbour Pond Dr., Wayne, NJ 07470 (“Distributor”).
Marketing and Sales Distribution Alliance AgreementMarketing and Sales Distribution Alliance Agreement • February 29th, 2012 • Novadaq Technologies Inc • Delaware
This Marketing and Sales Distribution Alliance Agreement (the “Agreement”) is made and entered into as of November 29, 2011 (the “Effective Date”) by and between KCI Medical Resources Ltd, a nonresident corporation organized, registered in, and existing under the laws of the Republic of Ireland, having its principal place of business at 122 Mart Street, Zephyr House, Grand Cayman, Cayman Islands (“KCI MR”) and Novadaq Technologies Inc., a corporation, having its headquarters at 2585 Skymark Avenue, Suite 306, Mississauga, Ontario, Canada L4W 4L5, together with its United States subsidiary Novadaq Corp. (“Novadaq”); KCI MR and Novadaq both together are referred to as the “Parties” and individually as a “Party.”
